44 assets in Endometrial Cancer

Lenvatinib

Pembrolizumab

Carboplatin

Cis-Diamminedichloroplatinum Ii

Adriamycin

Docetaxel

Disitamab Vedotin

Capecitabine

Fluorouracilum

Pembrolizumab/Vibostolimab Coformulation

Atezolizumab

Letrozole

Alnodesertib

Dostarlimab

Immunoglobulin G1, Anti-(Human Epidermal Growth Factor Receptor Her2) (Human-Mus Musculus Monoclonal Shr-1805 ?1-Chain), Complex With Human-Mus Musculus Monoclonal Shr-1805 ?-Chain, Dimer, Thioether With N-[6-(3-Mercapto-2,5-Dioxo-1-Pyrrolidinyl)-1-Oxohexyl]Glycylglycyl-L-Phenylalanyl-N-[[(1R)-1-Cyclopropyl-2-[[(1S,9S)-9-Ethyl-5-Fluoro-2,3,9,10,13,15-Hexahydro-9-Hydroxy-4-Methyl-10,13-Dioxo-1H,12H-Benzo[De]Pyrano[3?,4?:6,7]Indolizino[1,2-B]Quinolin-1-Yl]Amino]-2-Oxoethoxy]Methyl]Glycinamide

Teonanacatl

Oxaliplatin

Sitravatinib

Ataluren

Bmx-001 Free Base

Immunoglobulin G1 [101-Glycine,234-Phenylalanine,235-Glutamic Acid,265-Alanine,405-Leucine,De-C-Terminal-Lysine], Anti-(Human Cd3 Antigen) (Human-Mus Musculus Monoclonal Igg1-Hucacao-H101G-Feal ?1-Chain), Disulfide With Human-Mus Musculus Monoclonal Igg1-Hucacao-H101G-Feal ?-Chain, (234?226?),(237?229?)-Bis(Disulfide) With Immunoglobulin G1 [234-Phenylalanine,235-Glutamic Acid,265-Alanine,409-Arginine] Anti-(Human B7 Homolog 4 Protein) (Human Monoclonal Igg1-7724-084-N52S-Fear ?1-Chain) Disulfide With Human Monoclonal Igg1-7724-084-N52S-Fear ?-Chain

Immunoglobulin G4, Anti-(Human Programmed Cell Death Protein 1) (Human Monoclonal Regn2810 Heavy Chain), Disulfide With Human Monoclonal Regn2810 .Kappa.-Chain, Dimer

Nivolumab

Sarilumab

Tocilizumab

Ubamatamab

Vls-1488

Cetuximab

e7386

Olomorasib

Pasifolate Exatecan

ide034

p95her2.car-tech2me

Bl-M17D1

dm002

Felmetatug Vedotin

Itraconazole

ly4170156

ly4175408

ly4257496

nkt3447

nkt3964

pf-07260437

Sgn-Alpv